May 9, 2019
Takeda sells Xiidra to Novartis for up to $5.3B, TachoSil to Ethicon for $400M
Takeda sells Xiidra to Novartis for up to$5.3 billion, TachoSil to Ethicon for approximately $400 million
Pharmaceuticals, Biotechnology and Life Sciences
Category: Asia
May 9, 2019
Promethera doses patients with HepaStem testing drug for Liver Stem Cell Therapy in Late-Stage NASH
Promethera doses patients with HepaStem drug testing it in late stage non-alcoholic steatohepatitis
May 2, 2019
Smoothened Homolog (Protein Gx or SMO) Pipeline Review, H1 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Smoothened Homolog (Protein Gx or SMO) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s…
May 2, 2019
Hypoglycemia Pipeline Review, H1 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Hypoglycemia – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest pipeline guide…
May 2, 2019
Alzheimer’s Disease: Pipeline Review, Developer Landscape and Competitive Insights 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Alzheimer’s Disease: Pipeline Review, Developer Landscape and Competitive Insights” report has been added to ResearchAndMarkets.com’s offering. Alzheimer’s disease…
May 2, 2019
Post-Operative Pain – Pipeline Review, H1 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Post-Operative Pain – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical…
April 30, 2019
Sinovant Sciences net approval of Derazantinib’s Clinical Trial Application by the China National Medical Products Administration
Chinese registrational clinical trial for derazantinib to begin in 2H 2019 BURLINGTON, Mass.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24ARQL&src=ctag” target=”_blank”gt;$ARQLlt;/agt; lt;a href=”https://twitter.com/hashtag/arql?src=hash” target=”_blank”gt;#arqllt;/agt;–ArQule, Inc.’s…
April 30, 2019
Sinovac second half 2018 sales remains same, 2018 annual report on Form 20-F
Revenuegenerated by Hepatitis A vaccine increased by $12.0 million comparedto same period in 2017, which was offset by $13.6 million decrease in
April 29, 2019
Global $3.28 Billion Probiotic Supplements Market (2018-2027): Development of Dry Probiotic Supplements for Chronic Diseases will Fuel Growth at an Expected CAGR of 10.15% During 2018-2027 – ResearchAndMarkets.com
Based on the source, the market was dominated by the bacteria-basedprobiotic supplements segment, with a 91% share in 2017. Most probioticsupplements include bacterial strains, of which, Lactobacillus sp andBifidobacterium sp are used widely for the maintenance of healthymicrobiota.
April 25, 2019
Drug Addiction Pipeline Review, H1 2019 – Therapeutic Analysis of 28 Companies & Drug Profiles – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Drug Addiction – Pipeline Review, H1 2019” report has been added to ResearchAndMarkets.com’s offering. Drug Addiction – Pipeline…